MedCity News November 16, 2022
Risk-based quality management is a data monitoring approach that accelerates the drug development pathway without compromising on safety – and one that is enhanced by the use of technologies such as artificial intelligence.
Clinical trials have become increasingly expensive, time-consuming, and complex, leading sponsors to look for more efficient ways to conduct their business. Risk-based quality management (RBQM) is answering that call.
It is a data monitoring approach that accelerates the drug development pathway without compromising on safety – and one that is enhanced by the use of technologies such as artificial intelligence (AI).
AI, ML, and healthcare
Machine learning (ML) uses computer algorithms to achieve AI, i.e., a computer learning and mimicking human cognitive skills. ML models are designed...
Today's Sponsors
Today's Sponsor